Zacks Cuts Analog Devices to Hold as Consensus Target Sits at $460.55

Zacks Research downgraded Analog Devices (NASDAQ: ADI) from "strong-buy" to "hold" in a note to investors on Wednesday, breaking with a sell-side consensus that still reads "Moderate Buy" across 33 analysts. The consensus price target stands at $460.55, roughly 12.5% above Wednesday's opening price of $409.29. For finance teams tracking semiconductor exposure, the move changes the texture of coverage rather than the arithmetic: 29 analysts rate the stock Buy and four rate it Hold, so one shop's reset narrows the bullish margin at the margin.

What does the rest of the street say?

The downgrade sits against a run of positive revisions:

• TD Cowen lifted its target from $460.00 to $475.00 with a "buy" rating on Monday, October 19th.
• Arete Research raised its target from $487.00 to $490.00 with a "buy" rating on Thursday, August 20th.
• Needham & Company increased its target from $440.00 to $450.00, also "buy," on August 20th.
• Goldman Sachs restated a "buy" and raised its objective from $450.00 to $480.00 on Wednesday, August 19th.
• Weiss Ratings upgraded from "hold (c+)" to "buy (b-)" on Friday, August 21st.

Per MarketBeat.com, the average rating across the group is "Moderate Buy."

What do the valuation and balance-sheet numbers show?

ADI carries a market capitalization of $198.33 billion and trades at a P/E ratio (share price divided by trailing twelve-month earnings per share) of 48.55, with a PEG ratio (P/E adjusted for expected growth) of 0.99. Beta, the measure of volatility relative to the market, reads 1.24. The stock has moved between a one-year low of $224.25 and a one-year high of $445.91, and sits above both its fifty-day moving average of $393.97 and its 200-day average of $375.40.

The balance sheet stays conservative: a debt-to-equity ratio of 0.20, a current ratio (current assets over current liabilities) of 1.25, and a quick ratio of 0.91. That leverage profile is roughly a quarter of what heavy-capex semiconductor peers typically carry, which cushions the multiple debate.

How did the latest quarter land?

On Wednesday, August 19th, ADI reported quarterly EPS of $3.45, beating the consensus estimate of $3.34 by $0.11. Revenue came in at $4.02 billion against an expected $3.92 billion, up 39.2% year over year from a quarter that produced $2.05 in EPS. Return on equity reached 16.39% and net margin 29.79%. Management set Q4 2026 guidance of $3.710 to $4.010 in EPS; analysts forecast $12.88 for the full current year.

Are insiders selling?

Two disclosed transactions stand out. CFO Richard C. Puccio, Jr. sold 2,683 shares on Wednesday, August 26th at an average $374.56, totaling $1,004,944.48 — a 4.72% cut to his position that left him holding 54,177 shares worth about $20,292,537.12. The sale ran under a pre-arranged Rule 10b5-1 trading plan (a schedule set in advance to avoid insider-information concerns). Insider Vivek Jain sold 3,305 shares on Thursday, October 8th at an average $406.58, worth $1,343,746.90 and cutting his stake 7.56%; he retains 40,428 shares valued at $16,437,216.24. Insiders have sold 52,436 shares worth $20,681,906 over the last ninety days. Insider ownership stands at just 0.36%.

Where is institutional money moving?

Institutions hold 86.81% of the stock, and the flows leaned decisively inward. BlackRock opened a new position in the second quarter worth approximately $18,610,868,000 — the largest single print in the filing batch. VanEck Associates raised its stake 24.7% in Q2 to 8,422,883 shares worth $3,345,316,000. Bank of America added 501,604 shares in Q1 for a 5.2% increase, bringing its holding to 10,216,699 shares valued at $3,250,341,000. Amundi lifted its position 5.3% in Q1 to 5,044,271 shares worth $1,604,771,000, and Legal & General opened a new Q2 stake of $1,525,167,000.

For practitioners, the picture is a single dissenting Hold against crowded bullishness, near-record pricing, and institutional accumulation still running in one direction. The forward question is whether Q4 guidance inside the $3.71–$4.01 band holds the consensus target of $460.55 in place.